With eCLIP, m6A sequencing, and single‐cell Ribo‐STAMP (scRibo‐STAMP), they further explored alterations in the translatome at a single‐cell level within YTHDF2‐depleted solid tumors and highlighted the therapeutic potential of YTHDF2 in breast cancers (Einstein et al., 2021). Here, YTHDF2 is linked to breast carcinoma.